Doctor profile · Federal record

Dr. Jessica Dijulio, MA, MMS, PA-C

Dermatology Physician (CMS: Physician Assistant) · Philadelphia, PA

  • NPI 1578046603
  • Accepts Medicare
  • 8 yrs in practice
  • Female
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
833 Chestnut St
Philadelphia, PA 191074414
(484) 951-4055
Mailing address
833 Chestnut St Ste 740
Philadelphia, PA 191074409

Credentials & registration

NPPES · NUCC
NPI registered
September 2018 — 8 yrs on file
Profile last updated
July 14, 2020
Year of graduation
2018 — 8 yrs since
Specialty taxonomy
207N00000X — NUCC code
State license (1)
Pennsylvania #MA060109

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1578046603. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
4,014
Distinct HCPCS
10
Medicare allowed
$236,097
HCPCS Description Services Patients Avg allowed
17003 Destruction of precancer skin growth, 2-14 growths 1,283 222 $5
99214 Established patient office or other outpatient visit, 30-39 minutes 929 568 $104
17000 Destruction of precancer skin growth, 1 growth 389 301 $42
11102 Biopsy of related skin growth, first growth 385 322 $75
11103 Biopsy of related skin growth, each additional growth 294 167 $40
99204 New patient office or other outpatient visit, 45-59 minutes 249 249 $136
17110 Destruction of skin growth, 1-14 growths 218 187 $91
99213 Established patient office or other outpatient visit, 20-29 minutes 76 54 $74
17004 Destruction of precancer skin growth, 15 or more growths 62 49 $135
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg 37 15 $1

In context: peer comparison

Among 55 peers in this city , average services per provider: 169. This provider delivers 24× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$25,176
Transactions
213
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
Janssen Biotech, Inc. 55 $14,379.94
Incyte Corporation 11 $4,727.13
Verrica Pharmaceuticals Inc. 12 $3,207.72
E.R. Squibb & Sons, L.L.C. 19 $1,005.24
ABBVIE INC. 42 $590.02
LEO Pharma Inc. 15 $267.62
Dermavant Sciences, Inc. 14 $243.96
GENZYME CORPORATION 11 $199.64
SUN PHARMACEUTICAL INDUSTRIES INC. 13 $185.24
Novartis Pharmaceuticals Corporation 10 $135.48
Regeneron Healthcare Solutions, Inc. 2 $61.35
PFIZER INC. 3 $50.05
Galderma Laboratories, L.P. 3 $47.79
Lilly USA, LLC 2 $35.00
UCB, Inc. 1 $24.70

By nature of payment

Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
$14,120
Consulting Fee
$5,326
Food and Beverage
$3,875
Travel and Lodging
$1,766
Education
$88

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
1,070
Patients
649
Total drug cost
$28,302
Drug Type Claims Patients Total cost
Triamcinolone Acetonide Generic 274 209 $4,007
Ketoconazole Generic 226 105 $4,960
Doxycycline Hyclate Generic 113 90 $2,357
Mupirocin Generic 100 86 $940
Clobetasol Propionate Generic 86 42 $7,458
Fluocinonide Generic 54 31 $2,639
Clotrimazole Generic 45 23 $778
Hydroxyzine Hcl Generic 30 0 $170
Fluconazole Generic 28 19 $411
Clindamycin Phosphate Generic 24 17 $1,221

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Jessica Dijulio's medical specialty?
Dr. Jessica Dijulio practices Dermatology Physician in Philadelphia, PA.
Where does Dr. Jessica Dijulio practice?
Dr. Jessica Dijulio practices at 833 Chestnut St, Philadelphia, PA 191074414. Office phone: 4849514055.
What is Dr. Jessica Dijulio's NPI?
Dr. Jessica Dijulio's National Provider Identifier (NPI) is 1578046603, issued by NPPES.
Does Dr. Jessica Dijulio accept Medicare assignment?
Yes. Dr. Jessica Dijulio accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Jessica Dijulio commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99214); Destruction of precancer skin growth, 1 growth (HCPCS 17000). Source: CMS Medicare Physician & Other Practitioners file.